AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
NEUROPATHOLOGICAL CORRELATES OF AUDITORY EVENT-RELATED POTENTIALS IN RECENT-ONSET SCHIZOPHRENIA
Authors: UMBRICHT D BILDER R WU H JAVITT D KANE J
Citation: D. Umbricht et al., NEUROPATHOLOGICAL CORRELATES OF AUDITORY EVENT-RELATED POTENTIALS IN RECENT-ONSET SCHIZOPHRENIA, Schizophrenia research, 29(1-2), 1998, pp. 124-124
THE PREVALENCE OF ACUTE EXTRAPYRAMIDAL SIGNS AND SYMPTOMS IN PATIENTSTREATED WITH CLOZAPINE, RISPERIDONE, AND CONVENTIONAL ANTIPSYCHOTICS
Authors: MILLER CH MOHR F UMBRICHT D WOERNER M FLEISCHHACKER WW LIEBERMAN JA
Citation: Ch. Miller et al., THE PREVALENCE OF ACUTE EXTRAPYRAMIDAL SIGNS AND SYMPTOMS IN PATIENTSTREATED WITH CLOZAPINE, RISPERIDONE, AND CONVENTIONAL ANTIPSYCHOTICS, The Journal of clinical psychiatry, 59(2), 1998, pp. 69-75
EFFECTS OF CLOZAPINE ON AUDITORY EVENT-RELATED POTENTIALS IN SCHIZOPHRENIA
Authors: UMBRICHT D JAVITT D NOVAK G BATES J POLLACK S LIEBERMAN J KANE J
Citation: D. Umbricht et al., EFFECTS OF CLOZAPINE ON AUDITORY EVENT-RELATED POTENTIALS IN SCHIZOPHRENIA, Biological psychiatry, 44(8), 1998, pp. 716-725
NEUROPATHOLOGICAL CORRELATES OF AUDITORY EVENT-RELATED POTENTIALS IN RECENT-ONSET SCHIZOPHRENIA
Authors: UMBRICHT D BILDER R WU H JAVITT D KANE J
Citation: D. Umbricht et al., NEUROPATHOLOGICAL CORRELATES OF AUDITORY EVENT-RELATED POTENTIALS IN RECENT-ONSET SCHIZOPHRENIA, Biological psychiatry, 43, 1998, pp. 416-416
AUDITORY EVENT-RELATED POTENTIALS (ERP) IN FIRST EPISODE AND CHRONIC-SCHIZOPHRENIA
Authors: UMBRICHT D JAVITT D BATES J POLLAK S LIEBERMAN J KANE J
Citation: D. Umbricht et al., AUDITORY EVENT-RELATED POTENTIALS (ERP) IN FIRST EPISODE AND CHRONIC-SCHIZOPHRENIA, Biological psychiatry, 43, 1998, pp. 417-417
EFFECTIVENESS OF CLOZAPINE IN TREATMENT-RESISTANT SCHIZOPHRENIA
Authors: MARDER SR KANE JM SCHOOLER NR WIRSHING WC BAKER R AMES D UMBRICHT D GANGULI R BORENSTEIN M
Citation: Sr. Marder et al., EFFECTIVENESS OF CLOZAPINE IN TREATMENT-RESISTANT SCHIZOPHRENIA, Schizophrenia research, 24(1-2), 1997, pp. 187-187
FIRST IMPROVEMENT WITH CLOZAPINE - HOW PATIENT SHOULD WE BE
Authors: SCHOOLER N BORENSTEIN M AMES D BAKER R UMBRICHT D WIRSHING W KANE J MARDER S
Citation: N. Schooler et al., FIRST IMPROVEMENT WITH CLOZAPINE - HOW PATIENT SHOULD WE BE, Schizophrenia research, 24(1-2), 1997, pp. 188-188
PREDICTORS OF RESPONSE TO CLOZAPINE IN A LONG-TERM DOUBLE-BLIND TREATMENT STUDY
Authors: UMBRICHT D AMES D WIRSHING WC BAKER R CHENGAPPA R BORENSTEIN M SCHOOLER N MARDER S KANE J
Citation: D. Umbricht et al., PREDICTORS OF RESPONSE TO CLOZAPINE IN A LONG-TERM DOUBLE-BLIND TREATMENT STUDY, Schizophrenia research, 24(1-2), 1997, pp. 189-189
AUDITORY EVENT-RELATED POTENTIALS (ERP) IN FIRST EPISODE AND CHRONIC-SCHIZOPHRENIA
Authors: UMBRICHT D JAVITT D BATES J POLLAK S LIEBERMAN J KANE J
Citation: D. Umbricht et al., AUDITORY EVENT-RELATED POTENTIALS (ERP) IN FIRST EPISODE AND CHRONIC-SCHIZOPHRENIA, Schizophrenia research, 24(1-2), 1997, pp. 238-239
EVENT-RELATED POTENTIALS (ERP) DURING A VISUAL WORKING-MEMORY TASK INFIRST EPISODE AND CHRONIC-SCHIZOPHRENIA
Authors: UMBRICHT D JAVITT D BATES J POLLAK S LIEBERMAN J KANE J
Citation: D. Umbricht et al., EVENT-RELATED POTENTIALS (ERP) DURING A VISUAL WORKING-MEMORY TASK INFIRST EPISODE AND CHRONIC-SCHIZOPHRENIA, Schizophrenia research, 24(1-2), 1997, pp. 239-239
THE PREVALENCE OF ACUTE EXTRAPYRAMIDAL SIGNS AND SYMPTOMS IN PATIENTSTREATED WITH CLOZAPINE, RISPERIDONE AND CONVENTIONAL ANTIPSYCHOTICS
Authors: MILLER CH MOHR F UMBRICHT D WOERNER M FLEISCHHACKER WW LIEBERMAN J
Citation: Ch. Miller et al., THE PREVALENCE OF ACUTE EXTRAPYRAMIDAL SIGNS AND SYMPTOMS IN PATIENTSTREATED WITH CLOZAPINE, RISPERIDONE AND CONVENTIONAL ANTIPSYCHOTICS, Schizophrenia research, 24(1-2), 1997, pp. 265-266
CLOZAPINE VS HALOPERIDOL - DRUG INTOLERANCE IN A CONTROLLED 6 MONTH TRIAL
Authors: WIRSHING WC BAKER R UMBRICHT D AMES D SCHOOLER N KANE J MARDER SR BORENSTEIN D
Citation: Wc. Wirshing et al., CLOZAPINE VS HALOPERIDOL - DRUG INTOLERANCE IN A CONTROLLED 6 MONTH TRIAL, Schizophrenia research, 24(1-2), 1997, pp. 268-268
EVENT-RELATED POTENTIALS (ERP) DURING A VISUAL WORKING-MEMORY TASK INFIRST EPISODE SCHIZOPHRENIA
Authors: UMBRICHT D JAVITT D BATES J POLLAK S LIEBERMAN J KANE J
Citation: D. Umbricht et al., EVENT-RELATED POTENTIALS (ERP) DURING A VISUAL WORKING-MEMORY TASK INFIRST EPISODE SCHIZOPHRENIA, Biological psychiatry, 41, 1997, pp. 156-156
AUDITORY EVENT-RELATED POTENTIALS (ERP) IN FIRST EPISODE AND CHRONIC-SCHIZOPHRENIA
Authors: UMBRICHT D JAVITT D BATES J POLLAK S LIEBERMAN J KANE J
Citation: D. Umbricht et al., AUDITORY EVENT-RELATED POTENTIALS (ERP) IN FIRST EPISODE AND CHRONIC-SCHIZOPHRENIA, Biological psychiatry, 41, 1997, pp. 157-157
EFFICACY OF CLOZAPINE VERSUS HALOPERIDOL IN A LONG-TERM CLINICAL-TRIAL
Authors: KANE JM SCHOOLER NR MARDER S WIRSHING W AMES D UMBRICHT D SAFFERMAN A BAKER R GANGULI R
Citation: Jm. Kane et al., EFFICACY OF CLOZAPINE VERSUS HALOPERIDOL IN A LONG-TERM CLINICAL-TRIAL, Schizophrenia research, 18(2-3), 1996, pp. 9-9
THE EFFECT OF CLOZAPINE TREATMENT ON MISMATCH NEGATIVITY
Authors: UMBRICHT D NOVAK G JAVITT D POLLACK S LIEBERMAN J KANE J
Citation: D. Umbricht et al., THE EFFECT OF CLOZAPINE TREATMENT ON MISMATCH NEGATIVITY, Schizophrenia research, 18(2-3), 1996, p.
DEFICITS IN GENERATION OF AUDITORY EVENT-RELATED POTENTIALS, NEUROPSYCHOLOGICAL PERFORMANCE AND PSYCHOPATHOLOGY IN CHRONIC-SCHIZOPHRENIA
Authors: UMBRICHT D NOVAK G BILDER R JAVITT D BATES J POLLACK S LIEBERMAN J KANE J
Citation: D. Umbricht et al., DEFICITS IN GENERATION OF AUDITORY EVENT-RELATED POTENTIALS, NEUROPSYCHOLOGICAL PERFORMANCE AND PSYCHOPATHOLOGY IN CHRONIC-SCHIZOPHRENIA, Schizophrenia research, 18(2-3), 1996, p.
MEDICAL COMPLICATIONS OF NEW ANTIPSYCHOTIC-DRUGS
Authors: UMBRICHT D KANE JM
Citation: D. Umbricht et Jm. Kane, MEDICAL COMPLICATIONS OF NEW ANTIPSYCHOTIC-DRUGS, Schizophrenia bulletin, 22(3), 1996, pp. 475-483
DIFFERENTIAL-EFFECTS OF TYPICAL AND ATYPICAL ANTIPSYCHOTIC MEDICATIONON PLASMA PROLACTIN LEVELS
Authors: LEE H LIEBERMAN JA SHEITMAN B KOREEN AR KROENIG M MENDELOWITZ A UMBRICHT D ALVIR JMJ COOPER T
Citation: H. Lee et al., DIFFERENTIAL-EFFECTS OF TYPICAL AND ATYPICAL ANTIPSYCHOTIC MEDICATIONON PLASMA PROLACTIN LEVELS, Biological psychiatry, 39(7), 1996, pp. 100-100
THE EFFECTS OF CLOZAPINE TREATMENT ON AUDITORY EVENT-RELATED POTENTIALS (AERP)
Authors: UMBRICHT D NOVAK G JAVITT D POLLACK S LIEBERMAN J KANE J
Citation: D. Umbricht et al., THE EFFECTS OF CLOZAPINE TREATMENT ON AUDITORY EVENT-RELATED POTENTIALS (AERP), Biological psychiatry, 39(7), 1996, pp. 519-519
GENDER DIFFERENCES IN NEUROLEPTIC NONRESPONSIVE CLOZAPINE-TREATED SCHIZOPHRENICS
Authors: SZYMANSKI S LIEBERMAN J POLLACK S KANE JM SAFFERMAN A MUNNE R UMBRICHT D WOERNER M MASIAR S KRONIG M
Citation: S. Szymanski et al., GENDER DIFFERENCES IN NEUROLEPTIC NONRESPONSIVE CLOZAPINE-TREATED SCHIZOPHRENICS, Biological psychiatry, 39(4), 1996, pp. 249-254
EFFICACY OF CLOZAPINE VS HALOPERIDOL IN A LONG-TERM CLINICAL-TRIAL - PRELIMINARY FINDINGS
Authors: SCHOOLER N KANE J MARDER S BAKER R SAFFERMAN A WIRSHING W AMES D GANGULI R UMBRICHT D BORENSTEIN M
Citation: N. Schooler et al., EFFICACY OF CLOZAPINE VS HALOPERIDOL IN A LONG-TERM CLINICAL-TRIAL - PRELIMINARY FINDINGS, Schizophrenia research, 15(1-2), 1995, pp. 165-165
MISMATCH NEGATIVITY, NEUROPSYCHOLOGICAL DEFICITS AND PSYCHOPATHOLOGY IN CHRONIC-SCHIZOPHRENIA
Authors: UMBRICHT D NOVAK G BILDER R JAVITT D POLLACK S LIEBERMAN J KANE J
Citation: D. Umbricht et al., MISMATCH NEGATIVITY, NEUROPSYCHOLOGICAL DEFICITS AND PSYCHOPATHOLOGY IN CHRONIC-SCHIZOPHRENIA, Schizophrenia research, 15(1-2), 1995, pp. 187-188
MISMATCH NEGATIVITY DURING TREATMENT WITH CLOZAPINE
Authors: UMBRICHT D NOVAK G BILDER R JAVITT D POLLOCK S LIEBERMAN J KANE J
Citation: D. Umbricht et al., MISMATCH NEGATIVITY DURING TREATMENT WITH CLOZAPINE, Schizophrenia research, 15(1-2), 1995, pp. 187-187
RISPERIDONE - EFFICACY AND SAFETY
Authors: UMBRICHT D KANE JM
Citation: D. Umbricht et Jm. Kane, RISPERIDONE - EFFICACY AND SAFETY, Schizophrenia bulletin, 21(4), 1995, pp. 593-606
Risultati: 1-25 | 26-31